Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Articles by Review for PubMed (Select 23177553)

1.

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM.

Am J Med. 2013 Jan;126(1):13-20. doi: 10.1016/j.amjmed.2012.06.023. Epub 2012 Nov 20. Review.

PMID:
23177553
2.

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.

Can Fam Physician. 2014 Apr;60(4):324-33. Review.

3.

Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?

McClung M.

Clin Obstet Gynecol. 2013 Dec;56(4):743-8. doi: 10.1097/GRF.0b013e3182a98295. Review.

PMID:
24177063
4.

Bisphosphonates in the treatment of osteoporosis.

Diab DL, Watts NB.

Endocrinol Metab Clin North Am. 2012 Sep;41(3):487-506. doi: 10.1016/j.ecl.2012.04.007. Epub 2012 Jun 9. Review.

PMID:
22877426
5.

Long-term use of bisphosphonates in osteoporosis.

Watts NB, Diab DL.

J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65. doi: 10.1210/jc.2009-1947. Epub 2010 Feb 19. Review.

PMID:
20173017
6.

Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.

Reid IR.

Skeletal Radiol. 2011 Sep;40(9):1191-6. doi: 10.1007/s00256-011-1164-9. Epub 2011 Aug 17. Review.

PMID:
21847749
7.

Safety of bisphosphonates.

Orozco C, Maalouf NM.

Rheum Dis Clin North Am. 2012 Nov;38(4):681-705. doi: 10.1016/j.rdc.2012.09.001. Review.

PMID:
23137577
8.

Bisphosphonate drug holiday: choosing appropriate candidates.

Ro C, Cooper O.

Curr Osteoporos Rep. 2013 Mar;11(1):45-51. doi: 10.1007/s11914-012-0129-9. Review.

9.

Long-term risks of bisphosphonate therapy.

Watts NB.

Arq Bras Endocrinol Metabol. 2014 Jul;58(5):523-9. Review.

10.

Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back.

Salari P, Abdollahi M.

J Pharm Pharm Sci. 2012;15(2):305-17. Review.

11.

Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Lewiecki EM.

Drugs. 2011 Apr 16;71(6):791-814. doi: 10.2165/11585470-000000000-00000. Review.

PMID:
21504254
12.

Use of bisphosphonates in older adults: how long is long enough?

Dunn RL, Bird ML, Conway SE, Stratton MA.

Consult Pharm. 2013 Jan;28(1):39-57. doi: 10.4140/TCP.n.2013.39. Review.

PMID:
23315281
13.

Benefits and risks of bisphosphonate therapy for osteoporosis.

Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT.

J Clin Endocrinol Metab. 2012 Jul;97(7):2272-82. doi: 10.1210/jc.2012-1027. Epub 2012 Apr 20. Review.

PMID:
22523337
14.

Osteoporosis treatments and adverse events.

Solomon DH, Rekedal L, Cadarette SM.

Curr Opin Rheumatol. 2009 Jul;21(4):363-8. doi: 10.1097/BOR.0b013e32832ca433. Review.

PMID:
19412101
15.

Bisphosphonate adverse effects, lessons from large databases.

Abrahamsen B.

Curr Opin Rheumatol. 2010 Jul;22(4):404-9. doi: 10.1097/BOR.0b013e32833ad677. Review.

PMID:
20473174
16.

Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.

Cole RE.

Postgrad Med. 2011 Mar;123(2):131-44. doi: 10.3810/pgm.2011.03.2271. Review.

PMID:
21474901
17.

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

Reginster JY.

Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Review.

PMID:
21175240
18.

The bisphosphonates: risks and benefits of long term use.

Hermann AP, Abrahamsen B.

Curr Opin Pharmacol. 2013 Jun;13(3):435-9. doi: 10.1016/j.coph.2013.02.002. Epub 2013 Feb 21. Review.

PMID:
23434194
19.

[Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].

Ing Lorenzinit K, Meier R, Suva D, Dayer P, Desmeules J, Peter R.

Rev Med Suisse. 2012 Jun 6;8(344):1238-42. Review. French.

PMID:
22730621
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk